U.S. markets closed
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • Dow 30

    31,097.26
    +321.86 (+1.05%)
     
  • Nasdaq

    11,127.84
    +99.14 (+0.90%)
     
  • Russell 2000

    1,727.76
    +19.77 (+1.16%)
     
  • Crude Oil

    108.07
    -0.36 (-0.33%)
     
  • Gold

    1,811.70
    +10.20 (+0.57%)
     
  • Silver

    19.83
    +0.16 (+0.83%)
     
  • EUR/USD

    1.0440
    +0.0013 (+0.13%)
     
  • 10-Yr Bond

    2.8890
    -0.0830 (-2.79%)
     
  • GBP/USD

    1.2105
    +0.0002 (+0.01%)
     
  • USD/JPY

    135.0690
    -0.1060 (-0.08%)
     
  • BTC-USD

    19,245.59
    +30.51 (+0.16%)
     
  • CMC Crypto 200

    416.66
    -3.48 (-0.83%)
     
  • FTSE 100

    7,168.65
    -0.63 (-0.01%)
     
  • Nikkei 225

    26,236.01
    +300.39 (+1.16%)
     

Despite recent gains, Silk Road Medical, Inc (NASDAQ:SILK) insiders are still down US$8.9k after purchasing last year

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Insiders who bought US$103k worth of Silk Road Medical, Inc (NASDAQ:SILK) stock in the last year have seen some of their losses recouped as the stock gained 15% last week. However, the purchase is proving to be an expensive wager as insiders are yet to get ahead of their losses which currently stand at US$8.9k since the time of purchase.

While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

See our latest analysis for Silk Road Medical

Silk Road Medical Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider purchase was by President Erica Rogers for US$103k worth of shares, at about US$41.30 per share. That means that even when the share price was higher than US$37.74 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We always take careful note of the price insiders pay when purchasing shares. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. Erica Rogers was the only individual insider to buy shares in the last twelve months.

You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

Silk Road Medical is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership of Silk Road Medical

For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. Silk Road Medical insiders own about US$32m worth of shares. That equates to 2.4% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

So What Do The Silk Road Medical Insider Transactions Indicate?

The fact that there have been no Silk Road Medical insider transactions recently certainly doesn't bother us. On a brighter note, the transactions over the last year are encouraging. Overall we don't see anything to make us think Silk Road Medical insiders are doubting the company, and they do own shares. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Silk Road Medical. For example - Silk Road Medical has 2 warning signs we think you should be aware of.

Of course Silk Road Medical may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.